Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 144 No. 1314 (2014)

Nuclear power plants and childhood leukaemia: lessons from the past and future directions

  • Claudia Elisabeth Kuehni
  • Ben Daniel Spycher
DOI
https://doi.org/10.4414/smw.2014.13912
Cite this as:
Swiss Med Wkly. 2014;144:w13912
Published
23.03.2014

Summary

In the 1980s, leukaemia clusters were discovered around nuclear fuel reprocessing plants in Sellafield and Dounreay in the United Kingdom. This raised public concern about the risk of childhood leukaemia near nuclear power plants (NPPs). Since then, the topic has been well-studied, but methodological limitations make results difficult to interpret. Our review aims to: (1.) summarise current evidence on the relationship between NPPs and risk of childhood leukaemia, with a focus on the Swiss CANUPIS (Childhood cancer and nuclear power plants in Switzerland) study; (2.) discuss the limitations of previous research; and (3.) suggest directions for future research.

There are various reasons that previous studies produced inconclusive results. These include: inadequate study designs and limited statistical power due to the low prevalence of exposure (living near a NPP) and outcome (leukaemia); lack of accurate exposure estimates; limited knowledge of the aetiology of childhood leukaemia, particularly of vulnerable time windows and latent periods; use of residential location at time of diagnosis only and lack of data on address histories; and inability to adjust for potential confounders.

We conclude that risk of childhood leukaemia around NPPs should continue to be monitored and that study designs should be improved and standardised. Data should be pooled internationally to increase the statistical power. More research needs to be done on other putative risk factors for childhood cancer such as low-dose ionizing radiation, exposure to certain chemicals and exposure to infections. Studies should be designed to allow examining multiple exposures.

References

  1. Black D. Investigation of the Possible Increased Incidence of Cancer in West Cumbria; Report of the Independent Advisory Group. London: HMSO; 1984.
  2. Laurier D, Jacob S, Bernier MO, Leuraud K, Metz C, Samson E, et al. Epidemiological studies of leukaemia in children and young adults around nuclear facilities: a critical review. Radiat Prot Dosimetry. 2008;132(2):182–90.
  3. Laurier D, Grosche B, Hall P. Risk of childhood leukaemia in the vicinity of nuclear installations – findings and recent controversies. Acta Oncol. 2002;41(1):14–24.
  4. Committee on Medical Aspects of Radiation in the Environment (COMARE). Fourteenth report. Further consideration of the incidence of childhood leukaemia around nuclear power plants in Great Britain. Chilton: Health Protection Agency; 2011.
  5. Kaatsch P, Spix C, Jung I, Blettner M. Childhood leukemia in the vicinity of nuclear power plants in Germany. Dtsch Arztebl Int. 2008;105(42):725–32.
  6. Spycher BD, Feller M, Zwahlen M, Roosli M, von der Weid NX, Hengartner H, et al. Childhood cancer and nuclear power plants in Switzerland: a census-based cohort study. Int J Epidemiol. 2011;40(5):1247–60.
  7. Sermage-Faure C, Laurier D, Goujon-Bellec S, Chartier M, Guyot-Goubin A, Rudant J, et al. Childhood leukemia around French nuclear power plants – the Geocap study, 2002–2007. Int J Cancer. 2012;131(5):E769–80.
  8. Bollaerts K, Fierens S, Simons K, Francart J, Poffijjn A, Sonk M. Monitoring of Possible Health Effects of Living in the Vicinity of Nuclear Sites in Belgium. Brussels: Institut Scientifique de Santé Publique WIV-ISP; 2012.
  9. Koerblein A, Fairlie I. French geocap study confirms increased leukemia risks in young children near nuclear power plants. Int J Cancer. 2012;131(12):2970–1.
  10. Wakeford R. The risk of childhood leukaemia following exposure to ionising radiation – a review. J Radiol Prot. 2013;33(1):1–25.
  11. Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380(9840):499–505.
  12. Kendall GM, Little MP, Wakeford R, Bunch KJ, Miles JC, Vincent TJ, et al. A record-based case-control study of natural background radiation and the incidence of childhood leukaemia and other cancers in Great Britain during 1980–2006. Leukemia. 2013;27(1):3–9.
  13. BfS. Epidemiological Study of Childhood Cancer in the Vicinity of Nuclear Power Plants – KiKK Study. Concluding Statement of the Federal Office for Radiation Protection (September 2009). Salzgitter: Federal Office for Radiation Protection; 2009.
  14. United Nations Scientific Committee on the Effects of Atomic Radiation. UNSCEAR Report 2000, Sources and effects of ionizing radiation, vol. I Sources, Annex B, Exposures from natural radiation sources. United Nations; 2000.
  15. United Nations Scientific Committee on the Effects of Atomic Radiation. UNSCEAR Report 2000, Sources and effects of ionizing radiation, vol. I Sources, Annex C, Exposures from man-made sources of radiation. United Nations; 2000.
  16. Federal Office of Public Health. Umweltradioaktivität und Strahlendosen in der Schweiz. Swiss Federal Office of Public Health, Radiological Protection Division; 2011. German.
  17. Stiller CA, Marcos-Gragera R, Ardanaz E, Pannelli F, Almar Marques E, Canada Martinez A, et al. Geographical patterns of childhood cancer incidence in Europe, 1988–1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):1952–60.
  18. Mitter V, Michel G, Wölfli P, Gianinazzi M, Rüegg C, Sommer G, et al. Swiss Childhood Cancer Registry – Annual Report 2011/12. Bern: Institute of Social and Preventive Medicine (ISPM), University of Bern; 2013.
  19. Michel G, von der Weid NX, Zwahlen M, Redmond S, Strippoli MP, Kuehni CE, et al. Incidence of childhood cancer in Switzerland: the Swiss Childhood Cancer Registry. Pediatr Blood Cancer. 2008;50(1):46–51.
  20. Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh J-W, Lacour B, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet. 2004;364(9451):2097–105.
  21. Wiemels J. Perspectives on the causes of childhood leukemia. Chem Biol Interact. 2012;196(3):59–67.
  22. Pui CH, Carroll WL, Meshinchi S, Arceci RJ. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol. 2011;29(5):551–65.
  23. Enciso-Mora V, Hosking FJ, Sheridan E, Kinsey SE, Lightfoot T, Roman E, et al. Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia. 2012;26(10):2212–5.
  24. Portier C. Risk factors for childhood leukaemia. Discussion and summary. Radiat Prot Dosimetry. 2008;132(2):273–4.
  25. Little MP, Wakeford R, Kendall GM. Updated estimates of the proportion of childhood leukaemia incidence in Great Britain that may be caused by natural background ionising radiation. J Radiol Prot. 2009;29(4):467–82.
  26. Calvente I, Fernandez MF, Villalba J, Olea N, Nunez MI. Exposure to electromagnetic fields (non-ionizing radiation) and its relationship with childhood leukemia: a systematic review. Sci Total Environ. 2010;408(16):3062–9.
  27. Pyatt D, Hays S. A review of the potential association between childhood leukemia and benzene. Chem Biol Interact. 2010;184(1-2):151–64.
  28. Van Maele-Fabry G, Lantin AC, Hoet P, Lison D. Residential exposure to pesticides and childhood leukaemia: a systematic review and meta-analysis. Environ Int. 2011;37(1):280–91.
  29. Infante-Rivard C. Chemical risk factors and childhood leukaemia: a review of recent studies. Radiat Prot Dosimetry. 2008;132(2):220–7.
  30. Greaves M. Pre-natal origins of childhood leukemia. Rev Clin Exp Hematol. 2003;7(3):233–45.
  31. Wiemels J. Chromosomal translocations in childhood leukemia: natural history, mechanisms, and epidemiology. J Natl Cancer Inst Monogr. 2008(39):87–90.
  32. McNally RJ, Eden TO. An infectious aetiology for childhood acute leukaemia: a review of the evidence. Br J Haematol. 2004;127(3):243–63.
  33. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6(3):193–203.
  34. Steinmaus C, Lu M, Todd RL, Smith AH. Probability estimates for the unique childhood leukemia cluster in Fallon, Nevada, and risks near other U.S. Military aviation facilities. Environ Health Perspect. 2004;112(6):766–71.
  35. McNally RJ, Alexander FE, Vincent TJ, Murphy MF. Spatial clustering of childhood cancer in Great Britain during the period 1969–1993. Int J Cancer. 2009;124(4):932–6.
  36. Schmiedel S, Jacquez GM, Blettner M, Schuz J. Spatial clustering of leukemia and type 1 diabetes in children in Denmark. Cancer Causes Control. 2011;22(6):849–57.
  37. Demoury C, Goujon-Bellec S, Guyot-Goubin A, Hemon D, Clavel J. Spatial variations of childhood acute leukaemia in France, 1990–2006: global spatial heterogeneity and cluster detection at “living-zone” level. Eur J Cancer Prev. 2012;21(4):367–74.
  38. Basta NO, James PW, Craft AW, McNally RJ. Season of birth and diagnosis for childhood cancer in Northern England, 1968–2005. Paediatr Perinat Epidemiol. 2010;24(3):309–18.
  39. Sorensen HT, Pedersen L, Olsen J, Rothman K. Seasonal variation in month of birth and diagnosis of early childhood acute lymphoblastic leukemia. JAMA. 2001;285(2):168–9.
  40. Gustafsson B, Honkaniemi E, Goh S, Giraud G, Forestier E, von Dobeln U, et al. KI, WU, and Merkel cell polyomavirus DNA was not detected in guthrie cards of children who later developed acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2012;34(5):364–7.
  41. O’Connor SM, Boneva RS. Infectious etiologies of childhood leukemia: plausibility and challenges to proof. Environ Health Perspect. 2007;115(1):146–50.
  42. Committee on Medical Aspects of Radiation in the Environment (COMARE). Second Report. Investigation of the possible increased incidence of leukaemia in young people near the Dounreay Nuclear Establishment, Caithness, Scotland. London: HMSO; 1988.
  43. Baker PJ, Hoel DG. Meta-analysis of standardized incidence and mortality rates of childhood leukaemia in proximity to nuclear facilities. Eur J Cancer Care (Engl). 2007;16(4):355–63.
  44. Committee on the Analysis of Cancer Risks in Populations near Nuclear Facilities – Phase 1. Analysis of cancer risks in popoulation near nuclear facilities – Appendix A. Washington, D.C.: Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council; 2012.
  45. Spix C, Blettner M. Re: BAKER P.J. & HOEL D.G. (2007) European Journal of Cancer Care16, 355-363. Meta-analysis of standardized incidence and mortality rates of childhood leukaemia in proximity to nuclear facilities. Eur J Cancer Care (Engl). 2009;18(4):429–30.
  46. Laurier D, Hemon D, Clavel J. Childhood leukaemia incidence below the age of 5 years near French nuclear power plants. J Radiol Prot. 2008;28(3):401–3.
  47. Bithell JF, Keegan TJ, Kroll ME, Murphy MF, Vincent TJ. Childhood leukaemia near British nuclear installations: methodological issues and recent results. Radiat Prot Dosimetry. 2008;132(2):191–7.
  48. Spix C, Schmiedel S, Kaatsch P, Schulze-Rath R, Blettner M. Case-control study on childhood cancer in the vicinity of nuclear power plants in Germany 1980–2003. Eur J Cancer. 2008;44(2):275–84.
  49. Bithell JF, Keegan TJ, Kroll ME, Murphy MF, Vincent TJ. Reponse to Letter to the Editor. Radiat Prot Dosimetry. 2010;138(1):87–91.
  50. Heinavaara S, Toikkanen S, Pasanen K, Verkasalo PK, Kurttio P, Auvinen A. Cancer incidence in the vicinity of Finnish nuclear power plants: an emphasis on childhood leukemia. Cancer Causes Control. 2010;21(4):587–95.
  51. Michaelis J, Keller B, Haaf G, Kaatsch P. Incidence of childhood malignancies in the vicinity of west German nuclear power plants. Cancer Causes Control. 1992;3(3):255–63.
  52. Kaatsch P, Kaletsch U, Meinert R, Michaelis J. An extended study on childhood malignancies in the vicinity of German nuclear power plants. Cancer Causes Control. 1998;9(5):529-33.
  53. Wakeford R. Childhood leukaemia and radiation exposure of fathers – the end of the road, perhaps? J Radiol Prot. 2003;23(4):359–62.
  54. Committee on Medical Aspects of Radiation in the Environment (COMARE). Fourth Report. The incidence of cancer and leukaemia in young people in the vicinity of the Sellafield site, West Cumbria: Further studies and an update of the situation since the publication of the report of the Black Advisory Group in 1984. London: Department of Health; 1996.
  55. Kinlen L. Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet. 1988;2(8624):1323–7.
  56. Kinlen L, Doll R. Population mixing and childhood leukaemia: Fallon and other US clusters. Br J Cancer. 2004;91(1):1–3.
  57. Francis SS, Selvin S, Yang W, Buffler PA, Wiemels JL. Unusual space-time patterning of the Fallon, Nevada leukemia cluster: Evidence of an infectious etiology. Chem Biol Interact. 2012;196(3):102–9.
  58. Kinlen LJ. An examination, with a meta-analysis, of studies of childhood leukaemia in relation to population mixing. Br J Cancer. 2012;107(7):1163–8.
  59. Laplanche A, de Vathaire F. Leukaemia mortality in French communes (administrative units) with a large and rapid population increase. Br J Cancer. 1994;69(1):110–3.
  60. Koushik A, King WD, McLaughlin JR. An ecologic study of childhood leukemia and population mixing in Ontario, Canada. Cancer Causes Control. 2001;12(6):483–90.
  61. Wartenberg D, Schneider D, Brown S. Childhood leukaemia incidence and the population mixing hypothesis in US SEER data. Br J Cancer. 2004;90(9):1771–6.
  62. Bithell JF. The choice of test for detecting raised disease risk near a point source. Stat Med. 1995;14(21-22):2309–22.
  63. United Nations Scientific Committee on the Effects of Atomic Radiation. UNSCEAR Report 2000, Sources and effects of ionizing radiation, vol. I Sources, Annex A, Dose assessment methodologies. United Nations; 2000.
  64. Kaatsch P, Spix C, Schmiedel S, Schulze-Rath R, Mergenthaler A, Blettner M. Umweltforschungsplan des Bundesumweltministeriums (UFOPLAN). Reaktorsicherheit und Strahlenschutz. Vorhaben StSch 4334: Epidemiologische Studie zu Kinderkrebs in der Umgebung von Kernkraftwerken (KiKK-Studie). Zusammenfassung/Summary. Bundesamt für Strahlenschutz; 2010. German.
  65. Strahlenschutzkommission (SSK). Bewertung der epidemiologischen Studie zu Kinderkrebs in der Umgebung von Kernkraftwerken (KiKK-Studie). Stellungnahme der Strahlenschutzkommission. Berlin: H. Hoffmann GmbH – Fachverlag; 2008..
  66. Sermage-Faure C, Demoury C, Rudant J, Goujon-Bellec S, Guyot-Goubin A, Deschamps F, et al. Childhood leukaemia close to high-voltage power lines – the Geocap study, 2002–2007. Br J Cancer. 2013;108(9):1899–906.
  67. McLaughlin JR, Clarke EA, Nishri ED, Anderson TW. Childhood leukemia in the vicinity of Canadian nuclear facilities. Cancer Causes Control. 1993;4(1):51–8.
  68. Kaatsch P, Spix C, Schulze-Rath R, Schmiedel S, Blettner M. Leukaemia in young children living in the vicinity of German nuclear power plants. Int J Cancer. 2008;122(4):721–6.
  69. Wing S, Richardson DB, Hoffmann W. Cancer risks near nuclear facilities: the importance of research design and explicit study hypotheses. Environ Health Perspect. 2011;119(4):417–21.